Surgeon volume, prognosis post-esophageal cancer op linked

January 24, 2013
Surgeon volume, prognosis post-esophageal cancer op linked
For patients with esophageal cancer undergoing resection, surgeon volume, but not hospital volume, is independently associated with prognosis, according to research published online Jan. 7 in the Journal of Clinical Oncology.

(HealthDay)—For patients with esophageal cancer undergoing resection, surgeon volume, but not hospital volume, is independently associated with prognosis, according to research published online Jan. 7 in the Journal of Clinical Oncology.

To examine the influence of hospital and surgeon volume on survival after esophageal , Maryam Derogar, M.D., of the Karolinska Institute in Stockholm, and colleagues conducted a population-based cohort study involving 1,335 patients with esophageal cancer who underwent esophageal resection in 1987 to 2005. Participants were followed for survival until February 2011.

The researchers found that annual hospital volume was not independently associated with overall survival, and after adjustment for hospital clustering effects, hospital volume was not associated with short-term . Mortality occurring at least three months after surgery was significantly reduced with a combination of higher annual and cumulative surgeon volume, with a hazard ratio of 0.78 for surgeons with both annual and cumulative volume above versus below the median. The association persisted after adjustment for hospital and surgeon clustering.

"In conclusion, this large and population-based cohort study provided evidence that long-term survival is independently influenced by surgeon volume but not hospital volume," the authors write.

Explore further: Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Pre-op chemoradiotherapy ups survival in esophageal cancer

May 31, 2012

(HealthDay) -- For patients with esophageal or esophagogastric-junction cancer, treatment with neoadjuvant chemoradiotherapy followed by surgical resection is associated with improved survival compared with surgery alone, ...

Recommended for you

Researchers thwart cancer cells by triggering 'virus alert'

August 27, 2015

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.